Literature DB >> 31995699

Longer-Term Outcomes of the ProACT Trial.

David T Huang1, Donald M Yealy1, Derek C Angus1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31995699      PMCID： PMC7332226          DOI： 10.1056/NEJMc1910508

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection.

Authors:  David T Huang; Donald M Yealy; Michael R Filbin; Aaron M Brown; Chung-Chou H Chang; Yohei Doi; Michael W Donnino; Jonathan Fine; Michael J Fine; Michelle A Fischer; John M Holst; Peter C Hou; John A Kellum; Feras Khan; Michael C Kurz; Shahram Lotfipour; Frank LoVecchio; Octavia M Peck-Palmer; Francis Pike; Heather Prunty; Robert L Sherwin; Lauren Southerland; Thomas Terndrup; Lisa A Weissfeld; Jonathan Yabes; Derek C Angus
Journal:  N Engl J Med       Date:  2018-05-20       Impact factor: 91.245

2.  Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.

Authors:  Cédric Daubin; Xavier Valette; Fabrice Thiollière; Jean-Paul Mira; Pascal Hazera; Djillali Annane; Vincent Labbe; Bernard Floccard; François Fournel; Nicolas Terzi; Damien Du Cheyron; Jean-Jacques Parienti
Journal:  Intensive Care Med       Date:  2018-04-16       Impact factor: 17.440
  2 in total
  1 in total

1.  Procalcitonin-guided antibiotic therapy for pediatrics with infective disease: A updated meta-analyses and trial sequential analysis.

Authors:  Peng Li; JiaLe Liu; Junjun Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-09-21       Impact factor: 6.073
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.